251 related articles for article (PubMed ID: 30010473)
1. Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase.
Wójtowicz D; Cholewa D; Faba AM; Domańska B; Kokoszka J; Kopacz K; Ficek R; Irzyniec T; Rotkegel SE; Chudek J
Ren Fail; 2018 Nov; 40(1):384-389. PubMed ID: 30010473
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.
Van Hulle F; Bonkain F; De Clerck D; Aerden D; Vanwijn I; Tielemans C; Wissing KM
J Vasc Access; 2019 Jan; 20(1):60-69. PubMed ID: 29893163
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy.
Donati G; Colì L; Cianciolo G; La Manna G; Cuna V; Montanari M; Gozzetti F; Stefoni S
Artif Organs; 2012 Jan; 36(1):21-8. PubMed ID: 21848863
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.
Clase CM; Crowther MA; Ingram AJ; Cinà CS
J Thromb Thrombolysis; 2001 Apr; 11(2):127-36. PubMed ID: 11406727
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis catheter design and catheter performance: a randomized controlled trial.
Van Der Meersch H; De Bacquer D; Vandecasteele SJ; Van den Bergh B; Vermeiren P; De Letter J; De Vriese AS
Am J Kidney Dis; 2014 Dec; 64(6):902-8. PubMed ID: 24713222
[TBL] [Abstract][Full Text] [Related]
6. [Complications related to permanent deep venous catheterization using dual lumen hemodialysis catheter].
Zhang P; Yuan J; Chen JH; Wu JY; Zhang XH; Jiang H
Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):198-200. PubMed ID: 15059375
[TBL] [Abstract][Full Text] [Related]
7. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters (PASSPORT 1).
Kumwenda MJ; Mitra S; Khawaja A; Inston N; Nightingale P
J Vasc Access; 2019 Nov; 20(6):752-759. PubMed ID: 31466489
[TBL] [Abstract][Full Text] [Related]
8. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
Pollo V; Dionízio D; Bucuvic EM; Castro JH; Ponce D
Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
[TBL] [Abstract][Full Text] [Related]
9. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Shavit L; Lifschitz M; Plaksin J; Grenader T; Slotki I
Clin Nephrol; 2010 Oct; 74(4):297-302. PubMed ID: 20875382
[TBL] [Abstract][Full Text] [Related]
10. High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters.
Twardowski ZJ
Am J Kidney Dis; 1998 May; 31(5):841-7. PubMed ID: 9590195
[TBL] [Abstract][Full Text] [Related]
11. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
12. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
[TBL] [Abstract][Full Text] [Related]
13. Management of tunneled-cuffed catheter-related right atrial thrombosis in hemodialysis patients.
Yang H; Chen F; Jiao H; Luo H; Yu Y; Hong HG; Li Y; Fu P; Cui T
J Vasc Surg; 2018 Nov; 68(5):1491-1498. PubMed ID: 29804743
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin and calcium heparin in thrombosis prophylaxis in patients with percutaneous arterial and venous ports for colorectal liver metastases.
Zanon C; Bortolini M; Chiappino I
Tumori; 2005; 91(6):477-80. PubMed ID: 16457145
[TBL] [Abstract][Full Text] [Related]
15. Local low-dose thrombolysis for safe and effective treatment of venous port-catheter thrombosis.
Massmann A; Jagoda P; Kranzhoefer N; Buecker A
Ann Surg Oncol; 2015 May; 22(5):1593-7. PubMed ID: 25287441
[TBL] [Abstract][Full Text] [Related]
16. The use of streptokinase for restoration of patency to hemodialysis central venous catheters: a low-cost, safe and effective option.
Bashardoust B; Habibzadeh S; Sharghi A; Eskandari R; Maleki N
J Vasc Access; 2017 Sep; 18(5):e70. PubMed ID: 28777422
[No Abstract] [Full Text] [Related]
17. Is the removal of a central venous catheter always necessary in the context of catheter-related right atrial thrombosis?
Rossi L; Libutti P; Casucci F; Lisi P; Teutonico A; Basile C; Lomonte C
J Vasc Access; 2019 Jan; 20(1):98-101. PubMed ID: 29749281
[TBL] [Abstract][Full Text] [Related]
18. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
19. Managing peripherally inserted central catheter-related venous thrombosis: How I do it.
Chaitowitz I; Heng R; Bell K
Australas Radiol; 2006 Apr; 50(2):132-5. PubMed ID: 16635031
[TBL] [Abstract][Full Text] [Related]
20. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
